BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7379032)

  • 1. Nodular lymphoma: clinicopathologic correlations of parafollicular small lymphocytes and degree of nodularity.
    Colby TV; Hoppe RT; Burke JS
    Cancer; 1980 May; 45(9):2364-7. PubMed ID: 7379032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of growth pattern on survival in non-Hodgkin's lymphomas classified according to Lukes and Collins.
    Damber L; Lenner P; Lundgren E
    Pathol Res Pract; 1982 Jul; 174(1-2):42-52. PubMed ID: 7134063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coexistence of nodular and diffuse patterns in nodular non-Hodgkin's lymphomas: significance and clinicopathologic correlation.
    Warnke RA; Kim H; Fuks Z; Dorfman RF
    Cancer; 1977 Sep; 40(3):1229-33. PubMed ID: 332322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of parafollicular small lymphocytes in follicular lymphoma: clinicopathological studies of 82 cases of primary nodal origin.
    Ree HJ; Leone LA
    Cancer; 1978 Apr; 41(4):1500-10. PubMed ID: 346200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rappaport classification of non-Hodgkin's lymphoma: histologic features and clinical significance.
    Byrne GE
    Cancer Treat Rep; 1977 Sep; 61(6):935-44. PubMed ID: 332357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute.
    Garvin AJ; Simon RM; Osborne CK; Merrill J; Young RC; Berard CW
    Cancer; 1983 Aug; 52(3):393-8. PubMed ID: 6344979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective analysis of the clinical results in relation to the Rappaport histological classification.
    Brown TC; Peters MV; Bergsagel DE; Reid J
    Br J Cancer Suppl; 1975 Mar; 2():174-86. PubMed ID: 1182069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
    Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
    Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic types of diffuse large-cell lymphoma.
    Warnke RA; Strauchen JA; Burke JS; Hoppe RT; Campbell BA; Dorfman RF
    Cancer; 1982 Aug; 50(4):690-5. PubMed ID: 7093905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-hodgkin's lymphomas in Saskatchewan: a clinicopathologic study.
    Cherian T; Skinnider LF; Wright JL; Komjathy G
    Can Med Assoc J; 1978 Sep; 119(5):435-41. PubMed ID: 356951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular poorly differentiated lymphocytic lymphoma: changes in histology and survival.
    Ostrow SS; Diggs CH; Sutherland JC; Gustafson J; Wiernik PH
    Cancer Treat Rep; 1981; 65(11-12):929-33. PubMed ID: 7028254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma.
    Chen MG; Prosnitz LR; Gonzalez-Serva A; Fischer DB
    Cancer; 1979 Apr; 43(4):1245-54. PubMed ID: 445327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma in northern India. A retrospective analysis of 238 cases.
    Garg A; Dawar R; Agarwal V; Rustagi RK; Kochupillai V
    Cancer; 1985 Aug; 56(4):972-7. PubMed ID: 4016691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
    Vonderheid EC; Diamond LW; van Vloten WA; Scheffer E; Meijer CJ; Cashell AW; Hardman JM; Lai SM; Hermans J; Matthews MJ
    Cancer; 1994 Jan; 73(1):207-18. PubMed ID: 8275427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II.
    Paryani SB; Hoppe RT; Cox RS; Colby TV; Rosenberg SA; Kaplan HS
    Cancer; 1983 Dec; 52(12):2300-7. PubMed ID: 6416664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer Institute.
    Anderson T; DeVita VT; Simon RM; Berard CW; Canellos GP; Garvin AJ; Young RC
    Cancer; 1982 Dec; 50(12):2708-21. PubMed ID: 7139564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
    Miettinen M; Franssila KO; Saxén E
    Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].
    Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ
    Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.